About Klintoz Pharmaceuticals
Klintoz Pharmaceuticals is a Healthcare company based in Delhi (India) founded in 2005. Manufacturing and exporting of pharmaceutical formulations including generics and branded medicines. The company has 10 employees. Its Indian entity Klintoz Pharmaceuticals Private Limited reported revenue of ₹1.14 Cr. Klintoz Pharmaceuticals offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medicines and Export.
Company details
Klintoz is recognized as a manufacturer of pharmaceutical formulations, operating a WHO-GMP certified unit in Roorkee, India, as part of a global group with exports to Central Asian countries. Its production includes tablets, capsules, and oral liquids for therapeutic areas like antibiotics, anti-diabetics, and oncology products. Quality assurance is maintained through certifications, and expertise in generics is utilized to supply health care products globally, with a commitment to innovative medicines development.
- Headquarters Delhi, India
- Employees 10
- SectorsHealthcare
- Email••••••••
- Website klintoz.com
- Social LinkedIn X
- Legal Name Klintoz Pharmaceuticals Private Limited
- Date of Incorporation 23 Jul, 2003
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹1.14 Cr
FY 2026 · -9% YoY
- Net Loss-₹41.7 Lakh
FY 2026 · -38% margin
- EBITDA-₹21.3 Lakh
FY 2026 · -19% margin
- Employee Count10
Associated legal entities of Klintoz Pharmaceuticals
Klintoz Pharmaceuticals operates through Klintoz Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Klintoz Pharmaceuticals Private Limited CIN U24239DL2003PTC121451 | Active | 23 Jul 2003 | New Delhi, Delhi | ₹1.1 Cr | 31 | 3 | View details |
Products & Services of Klintoz Pharmaceuticals
Klintoz Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets for various therapeutic uses such as antibiotics and cardiovascular treatments are manufactured by Klintoz.
Capsules covering therapeutic classes like anti-diabetics and anti-inflammatories are produced by Klintoz.
Board of directors of Klintoz Pharmaceuticals Private Limited (Klintoz Pharmaceuticals)
Klintoz Pharmaceuticals Private Limited is the primary company behind Klintoz Pharmaceuticals. The board of Klintoz Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Raj Kishor Singh, appointed in 2003. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Raj Kishor Singh DIN 00240190 | Director | 23 Jul 2003 | 23 yrs 3 mo | Klintoz Pharmaceuticals Private Limited |
| Amita Singh DIN 00246213 | Director | 02 Apr 2007 | 19 yrs 7 mo | Klintoz Pharmaceuticals Private Limited |
| Aditya Vikram Roy Chowdhury DIN 01483225 | Director | 30 Mar 2024 | 2 yrs 7 mo | Klintoz Pharmaceuticals Private Limited |
Financials of Klintoz Pharmaceuticals
Figures of Klintoz Pharmaceuticals Private Limited, the primary company behind Klintoz Pharmaceuticals, for FY 2026. Revenue was ₹1.14 Cr (-9% year on year). Net loss was -₹41.7 Lakh (-38% margin). EBITDA was -₹21.3 Lakh (-19% margin). Revenue has grown at a compounded annual rate of 0% over three years and 0% over five years.
- ₹1.14 CrRevenue · FY 2026 · -9% YoY
- -₹41.7 LakhNet loss · -38% margin
- -₹21.3 LakhEBITDA · -19% margin
- ₹10.38 CrPaid-up capital
- 31Employees (provident fund records)
- 0%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Klintoz Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Klintoz Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Klintoz Pharmaceuticals
Klintoz Pharmaceuticals was founded in 2005.
Klintoz Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Klintoz Pharmaceuticals has 10 employees.
The primary company behind Klintoz Pharmaceuticals, Klintoz Pharmaceuticals Private Limited, reported revenue of ₹1.14 Cr for FY 2026, down 9% year on year.
Klintoz is recognized as a manufacturer of pharmaceutical formulations, operating a WHO-GMP certified unit in Roorkee, India, as part of a global group with exports to Central Asian countries. Its production includes tablets, capsules, and oral liquids for therapeutic areas like antibiotics, anti-diabetics, and oncology products. Quality assurance is maintained through certifications, and expertise in generics is utilized to supply health care products globally, with a commitment to innovative medicines development.
Klintoz Pharmaceuticals offers Tablets and Capsules.
Klintoz Pharmaceuticals operates through Klintoz Pharmaceuticals Private Limited.
The legal entities of Klintoz Pharmaceuticals currently have 3 directors, including Amita Singh, Raj Kishor Singh, Aditya Vikram Roy Chowdhury.